Immunic, Inc. (IMUX) vs MediciNova, Inc. (MNOV)
Immunic, Inc. and MediciNova, Inc. are both Biotechnology companies. Immunic, Inc. and MediciNova, Inc. are of similar size ($132.9M and $127.2M). Immunic, Inc. has the higher net margin (0.00% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 13 metrics below, Immunic, Inc. leads on 7 and MediciNova, Inc. on 6.
Valuation
Profitability
| Metric | IMUX | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 37.76% | 65.16% |
| Operating margin | 0.00% | (1,287.53%) | 0.00% |
| Net margin | 0.00% | (1,168.31%) | 0.00% |
| Free cash flow margin | 0.00% | (991.31%) | 0.00% |
| Return on equity | (138.17%) | (25.56%) | (57.72%) |
| Return on assets | (101.15%) | (23.83%) | (49.22%) |
| Return on invested capital | 0.00% | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack